We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
African Pioneer Plc | LSE:ASP | London | Ordinary Share | IM00B8C0HK22 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | 3.50 | 4.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
14/8/2007 13:04 | It looks to me like the price was engineered to let some large holders swap their shares about. The fall was far too much for the slightly below expectation warning. If the large buyers and sellers are done, i would expect this to quickly bounce back over 50p. I may even add a few more myself! | currypasty | |
13/8/2007 12:15 | this is a very sound biz and conservatively accounted (if it capitalised in -process R&D, you'd add 25% to stated eps). Broker guidance doesn't include upside from NHS 'catalogue'. 15x calendar 08 for 20% gr and possibly twice that from catalgue upside is not expensive. 65% revenue is repeat biz from IT maintenance contratcs. Stock on its knees and some holders selling.. typical AIM lunacy | peter the pieman | |
01/8/2007 14:13 | NHS contracts - can make or brake a company. Delays seem to be the rule. - IMHO | piedro | |
30/7/2007 17:27 | It wasn't really much of a profit warning. Slightly below expectations implies less than 10% so they probably did hit the targets for the acquired business. | wjccghcc | |
30/7/2007 16:28 | RNS Number:1136B Ascribe plc 30 July 2007 Ascribe plc ("Ascribe" or "the Group") Issue of Equity Ascribe plc (AIM:ASP), the health IT Group, has applied to AIM for admission of 2,010,517 ordinary shares of 1p each in the Company ("Ordinary Shares") to be issued to the vendors of the Jade Health IT business ("Jade") as an earnout agreed at the time of acquisition. The acquisition of Jade was announced on 11 May 2006. Admission is expected to become effective on 1 August 2007. The total number of voting Ordinary Shares in issue following the additional listing will be 116,334,593. may 2006 rns.. The initial consideration of #2.73 million is to be satisfied by #1.5m in cash and #1.23m by the issue of 3,804,516 new ordinary shares in Ascribe plc. In addition, a deferred consideration of up to #0.65m is payable, approximately 14 months after completion, subject to the business achieving certain sales and profit targets so have we hit those targets or not, and if we have, why the profit warning... is it just coincidence the shareprice is back where it started at the start of this deal.. shareprice was 63, now 38 all smells a little fishy | currypasty | |
24/7/2007 07:15 | RNS Number:7249A Ascribe plc 24 July 2007 Press Release 24 July 2007 Ascribe plc ("Ascribe" or "the Group") Trading Update Ascribe plc (AIM:ASP), the health IT Group, today announces an update on current trading in advance of its final results for the year ended 30 June 2007, to be announced on 19 September 2007. Ascribe's business model is to supply health IT solutions directly to healthcare providers at a local level in the UK and overseas. During 2007 the Group has continued to expand its capacity by maximising operational synergies through the transfer of products to a more efficient web-based platform and through further recruitment. The Group is therefore in a position to take full advantage of the market it operates in and the opportunities available. Business levels in the UK reflect the annual NHS procurement cycle as well as localised purchasing processes. Uncertainty over the National Programme for IT moving to local procurement has distorted investment decisions and led to a number of delays in customer orders which would otherwise have been received towards the end of our financial year. Additionally, as we install new web-based IT systems and as we have introduced new operational solutions there have also been some delays to contract implementations. As a consequence of these delays and our investment in personnel, Group turnover and profits for the year ended 30 June 2007 are expected to be slightly below market expectations. The Group continues its active negotiations on all delayed contracts and expects that they will be delivered within the year ending 30 June 2008. It is pleasing that a number of these contracts have already been delivered in recent weeks. The feedback received from customers about the new products and integrated offerings gives the Board confidence in the Group's prospects for 2007/8. A number of customers have already extended their contracts this year, providing increased confidence about long-term maintenance income, which still exceeds 60% of forecast turnover in the current financial year. Taking into consideration the maintenance revenue, order book and a healthy prospect list arising from a high level of tendering activity, both in the UK and overseas, the Board is confident that the Group will deliver against expectations for 2007/8. | currypasty | |
16/7/2007 07:54 | Ascribe plc ("Ascribe" or "the Group") Non-Executive Director Appointment Ascribe plc (AIM:ASP), the health IT Group, announces that Ian Priestner has been appointed to the Board as an independent Non-Executive Director, with immediate effect. Ian (50) is currently a Non-Executive Director of the Walton Centre for Neurology and Neurosurgery NHS Trust. During the last ten years, Ian has worked as Head of Public Policy and Government Relations (UK and International) for British Gas plc (holding brand for Transco and BG Group), and was Group Director of Corporate Communications for United Utilities PLC where he was a member of the Executive Leadership Team from 2000 to 2006. In 1979, Ian worked for the Confederation of British Industry in its International Affairs department and later moved to become the Public Affairs Specialist for the United States Embassy in London. In 1986, Ian became Chief Press Officer for the Social Democratic Party. He later became a Communications Consultant for Lowe Bell and Public Affairs Manager for Conoco (UK) Ltd. Ian holds degrees in International Relations and Law. David Hughes, currently a Non-Executive Director of Ascribe with four years service, will move to the role of Non-Executive Deputy Chairman and also chair the Audit and Remuneration Committees. Commenting on the appointments Stephen Critchlow, Executive Chairman of Ascribe plc, said: "We are delighted that Ian is joining the Board of Ascribe. His strong background in both government relations and healthcare will be a valuable asset to the Group as we expand our capability and market. Together with David Hughes, we have a strong Non-Executive team." | currypasty | |
13/7/2007 14:30 | charts & share prices from www.advfn.com'>free stock charts from www.advfn.com | currypasty | |
13/7/2007 14:26 | Any reason for this fall? There seems to be constant selling here? | thewolf | |
11/7/2007 18:11 | Added a few at 53p. Hope it drops a bit further. | wjccghcc | |
11/7/2007 17:17 | lots of big trades today 1 mil+ volume, and down 4p... looks like price walked down to a level to match up big buyers to sellers | currypasty | |
11/6/2007 12:19 | well, someone bought £10k's worth this morning ! 3 mm bid, 3 mm ask, 1 blue today, following the buy | currypasty | |
09/6/2007 08:38 | Been looking through the info and thread I find this share very interesting - am considering taking a position here. Is this a good moment to buy or should I bide my time? Any comments? TIA Shirely | shirelyshare | |
08/6/2007 15:28 | RNS Number:0656Y Ascribe plc 08 June 2007 Ascribe plc (the "Company") Holding in Company The Company received notification on 7 June 2007 from Morgan Stanley Securities Limited ("Morgan Stanley") that on 5 June 2007 Morgan Stanley had a notifiable interest in the Company of 11,256,599 ordinary shares of 1p each in the Company, representing 9.84 per cent. of the Company's current issued ordinary share capital. | currypasty | |
05/6/2007 16:15 | 62.0 - 64.0 , up 0.75
high volume 1.6 mil, traded today | currypasty | |
29/5/2007 08:30 | blasted through 60p, sitting at equal all time high ! | currypasty | |
24/5/2007 15:59 | bit of a jump up today, after 3 months consolidating, I would guess we are due another bite at 60p | currypasty | |
11/5/2007 14:23 | 11 May 2007 Ascribe plc (the "Company") Holding in Company The Company received notification on 10 May 2007 from Morgan Stanley Securities Limited ("Morgan Stanley") that on 8 May 2007 Morgan Stanley increased its interest in the Company which resulted in a total holding of 12,056,599 ordinary shares of 1p each in the Company, representing 10.54 per cent. of the Company's current issued ordinary share capital. | currypasty | |
08/5/2007 13:05 | 750k broker to broker trade at 58.3 pretty large trade, encouraging that someone think they are worth spending nearly half a mil on | currypasty | |
27/4/2007 16:07 | RNS Number:6763V Ascribe plc 27 April 2007 Ascribe plc (the "Company") Holding in Company The Company received notification on 26 April 2007 by Morgan Stanley Securities Limited ("Morgan Stanley") that on 24 April 2007 Morgan Stanley acquired a further interest that resulted in a total holding of 11,706,599 ordinary shares of 1p each in the Company, representing 10.24 per cent. of the Company's current issued ordinary share capital. | currypasty | |
26/4/2007 12:25 | up 1.75, after 4 market maker trades in a row ! | currypasty | |
30/3/2007 11:53 | rather interesting | via con | |
23/3/2007 16:13 | Marlborough Fund Managers top-slicing then? - down from 6,725,000 (5.89%) on 5-Jan. | gac100 | |
23/3/2007 16:01 | RNS Number:6267T Ascribe plc 23 March 2007 Ascribe plc (the "Company") Holding in Company The Company was informed on 22 March 2007 by Marlborough Fund Managers Limited ("MFML") that MFML is interested in 5,350,000 ordinary shares of 1p each in the Company, representing 4.68 per cent. of the Company's current issued ordinary share capital | currypasty | |
22/3/2007 08:04 | another cracking start to the day 62.0 - 64.0 | currypasty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions